Patents by Inventor Philip Edwin Pinder

Philip Edwin Pinder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay method
    Patent number: 7045280
    Abstract: The present invention provides a method for the measurement of the activity of a plasminogen activator, such as urokinase plasminogen activator (uPA) or tissue plasminogen activator (tPA) in a biological sample using an assay method characterized by the inclusion of an elastase inhibitor in the assay mixture. The invention also provides a diagnostic kit for the measurement of a plasminogen activator using said method and a method of determining the effective therapeutic dose of a plasminogen activator inhibitor using said method. Also provided is a method of preparing a pharmaceutical composition.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: May 16, 2006
    Assignee: AstraZeneca AB
    Inventors: Paul Elvin, Philip Edwin Pinder
  • Plasminogen Activator Assay Involving an Elastase Inhibitor
    Publication number: 20040211940
    Abstract: The present invention provides a method for the measurement of the activity of a plasminogen activator, such as urokinase plasminogen activator (uPA) or tissue plasminogen activator (tPA) in a biological sample using an assay method characterized by the inclusion of an elastase inhibitor in the assay mixture. The invention also provides a diagnostic kit for the measurement of a plasminogen activator using said method and a method of determining the effective therapeutic dose of a plasminogen activator inhibitor using said method. Also provided is a method of preparing a pharmaceutical composition.
    Type: Application
    Filed: May 17, 2002
    Publication date: October 28, 2004
    Applicant: AstraZeneca AB
    Inventors: Paul Elvin, Philip Edwin Pinder